Breaking News Instant updates and real-time market news.

MRK

Merck

$63.89

0.89 (1.41%)

08:04
05/19/17
05/19
08:04
05/19/17
08:04

Merck receives positive CHMP opinion recommending approval of Isentress 600mg

Merck announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of ISENTRESS 600 mg film-coated tablets, in combination with other anti-retroviral medicinal products, for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. In adults and pediatric patients, the recommended dosage is 1,200 mg once daily for treatment-naive patients or patients who are virologically suppressed on an initial regimen of ISENTRESS 400 mg twice daily. The recommendation will now be reviewed by the European Commission for marketing authorization in the European Union. A decision on approval is expected in the second half of 2017. The once daily formulation of ISENTRESS is currently under review in the United States by the Food and Drug Administration. The CHMP positive opinion was based on findings from the ONCEMRK trial, an ongoing Phase 3 multicenter, double-blind, randomized, active comparator-controlled clinical trial designed to evaluate the efficacy and safety of ISENTRESS 1200 mg, given as two 600 mg oral tablets once daily, compared to ISENTRESS 400 mg twice daily, each in combination with emtricitabine + tenofovir disoproxil fumarate in previously untreated HIV-1 infected adults. Once-daily ISENTRESS 600 mg, when used as part of an HIV-1 treatment regimen, demonstrated comparable efficacy and safety to ISENTRESS 400 mg twice a day after 48-weeks of treatment across a variety of patient populations.

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

MRK Merck
$63.89

0.89 (1.41%)

04/04/17
STFL
04/04/17
NO CHANGE
STFL
NewLink Genetics should be bought on weakness after data, says Stifel
Stifel analyst Stephen Willey said NewLink Genetics' (NLNK) combination of indoximod and Merck's (MRK) pembrolizumab in patients with treatment-naive melanoma demonstrated an overall response rate, or ORR, that is "essentially identical" to the previously-reported results from the Incyte (INCY)-Merck study of epacadostat/pembrolizumab. The lower rate of complete responses he doesn't "find terribly surprising" given what is already known about the current indoximod formulation, he tells investors. Willey, who views today's weakness as an interesting buying opportunity ahead of P1/2 data on the atezolizumab + GDC-0919 combination, keeps a Buy rating on Newlink shares.
04/20/17
JEFF
04/20/17
NO CHANGE
Target $51
JEFF
Underperform
Jefferies lowers Merck estimates, drops target to $51
Jefferies analyst Jeffrey Holford lowered his earnings estimates for Merck by up to 3% citing concerns on pricing for Januvia/Janumet. The analyst notes that his mid-term estimates are now up to 11% below consensus. Holford expects Keytruda, Januvia and Gardasil to miss expectations Q1. He cut his price target for Merck to $51 from $52 and keeps an Underperform rating on the name.
05/03/17
BMOC
05/03/17
NO CHANGE
BMOC
Merck results more positive than first appeared, says BMO Capital
BMO Capital analyst Alex Arfaei says he's more upbeat on Merck's Q1 results following its conference call. He says that the lower than expected Januvia revenue is "explainable," while the company's Keytruda drug looks set to beat expectations in 2H17. The analyst expects the company's 2017 results to come in at the top half of its guidance range, and he thinks the stock can rise, driven by Keytruda and its hepatitis C treatments. The analyst keeps an Outperform rating on the shares.
05/11/17
BMOC
05/11/17
NO CHANGE
BMOC
Merck Keytruda approval positive, says BMO Capital
BMO Capital analyst Alex Arfaei notes that the FDA approved Keytruda + chemo in first line NSCLC. The analyst says that the label is "solid," and he expects "strong uptake" for the drug in the condition, based on his checks with oncologists. The analyst raised his price target on the shares to $74 from $71 and keeps an Outperform rating on the stock.

TODAY'S FREE FLY STORIES

WFC

Wells Fargo

$54.17

-0.71 (-1.29%)

10:14
07/22/17
07/22
10:14
07/22/17
10:14
Periodicals
Wells Fargo investigating information sent to attorney, Bloomberg reports »

Wells Fargo said it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 15

    Jan

COKE

Coca-Cola Bottling

$240.86

-0.94 (-0.39%)

09:51
07/22/17
07/22
09:51
07/22/17
09:51
Hot Stocks
Coca-Cola Bottling announces 25c dividend for third quarter »

Coca-Cola Bottling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$88.61

0.01 (0.01%)

09:41
07/22/17
07/22
09:41
07/22/17
09:41
Periodicals
Procter & Gamble finds itself 'besieged again,' Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

PG

Procter & Gamble

$88.61

0.01 (0.01%)

09:40
07/22/17
07/22
09:40
07/22/17
09:40
Periodicals
Procter & Gamble finds itself 'besieged again,' Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

DF

Dean Foods

$15.35

-0.02 (-0.13%)

09:33
07/22/17
07/22
09:33
07/22/17
09:33
Periodicals
Cheddar prices could rise further, Barron's says »

Prices for block cheddar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

KR

Kroger

, FDX

FedEx

$212.51

0.63 (0.30%)

09:25
07/22/17
07/22
09:25
07/22/17
09:25
Periodicals
Issuing debt to fund pensions 'not cause for worry,' Barron's says »

Issuing debt to fund…

KR

Kroger

FDX

FedEx

$212.51

0.63 (0.30%)

DAL

Delta Air Lines

$52.26

-0.57 (-1.08%)

DD

DuPont

$84.54

-0.29 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SRPT

Sarepta

$43.41

2.48 (6.06%)

09:14
07/22/17
07/22
09:14
07/22/17
09:14
Periodicals
Upbeat sales news, guidance boost lift Sarepta shares, Barron's reports »

Sarepta's shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

, SHLD

Sears

$8.83

-0.77 (-8.02%)

09:09
07/22/17
07/22
09:09
07/22/17
09:09
Periodicals
Nothing is 'Amazon-proof,' Barron's says »

Amazon's (AMZN) deal…

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

SHLD

Sears

$8.83

-0.77 (-8.02%)

HD

Home Depot

$146.65

-0.38 (-0.26%)

LOW

Lowe's

$73.84

1.28 (1.76%)

BBY

Best Buy

$54.14

0.18 (0.33%)

M

Macy's

$23.36

0.29 (1.26%)

KSS

Kohl's

$40.46

0.47 (1.18%)

ORLY

O'Reilly Automotive

$188.19

-0.5 (-0.26%)

AAP

Advance Auto Parts

$105.27

2.04 (1.98%)

WFM

Whole Foods

$41.71

-0.05 (-0.12%)

KR

Kroger

COST

Costco

$150.44

-0.55 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 27

    Jul

  • 15

    Aug

  • 23

    Aug

  • 29

    Aug

BA

Boeing

$212.14

1.86 (0.88%)

, LMT

Lockheed Martin

$289.12

-0.55 (-0.19%)

08:58
07/22/17
07/22
08:58
07/22/17
08:58
Periodicals
Aviation, defense stocks have 'juicy yields,' Barron's says »

Some aerospace and…

BA

Boeing

$212.14

1.86 (0.88%)

LMT

Lockheed Martin

$289.12

-0.55 (-0.19%)

UTX

United Technologies

$123.49

1.04 (0.85%)

RTN

Raytheon

$169.37

0.59 (0.35%)

LLL

L3 Technologies

$176.62

-1.1 (-0.62%)

GD

General Dynamics

$204.55

2.15 (1.06%)

NOC

Northrop Grumman

$265.30

0.53 (0.20%)

COL

Rockwell Collins

$109.31

-0.04 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 28

    Jul

  • 15

    Aug

  • 23

    Aug

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

, GOOGL

Alphabet Class A

$993.84

1.65 (0.17%)

08:50
07/22/17
07/22
08:50
07/22/17
08:50
Periodicals
Amazon, others could be threat to fiberoptic markers, Barron's says »

Amazon.com (AMZN),…

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

GOOGL

Alphabet Class A

$993.84

1.65 (0.17%)

GOOG

Alphabet

$972.92

4.77 (0.49%)

AAPL

Apple

$150.27

-0.07 (-0.05%)

FB

Facebook

$164.43

-0.1 (-0.06%)

AAOI

Applied Optoelectronics

$89.95

1.15 (1.30%)

LITE

Lumentum

$63.35

2.9 (4.80%)

OCLR

Oclaro

$9.90

0.04 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Jul

  • 27

    Jul

  • 01

    Aug

  • 02

    Aug

  • 03

    Aug

  • 05

    Sep

  • 13

    Sep

  • 13

    Sep

NKE

Nike

$59.95

0.85 (1.44%)

, FB

Facebook

$164.43

-0.1 (-0.06%)

08:28
07/22/17
07/22
08:28
07/22/17
08:28
Periodicals
AllianceBernstein's Caruso sees EPS as 'poor' report card, Barron's says »

Frank Caruso, the chief…

NKE

Nike

$59.95

0.85 (1.44%)

FB

Facebook

$164.43

-0.1 (-0.06%)

ISRG

Intuitive Surgical

$927.47

-44.26 (-4.55%)

ANET

Arista Networks

$152.92

-3.88 (-2.47%)

AB

AllianceBernstein

$24.75

0.1 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 03

    Aug

  • 08

    Aug

  • 16

    Aug

  • 17

    Aug

  • 21

    Aug

  • 13

    Sep

FLEX

Flex

$16.74

-0.07 (-0.42%)

, AAPL

Apple

$150.27

-0.07 (-0.05%)

07:53
07/22/17
07/22
07:53
07/22/17
07:53
Periodicals
Flex could rise 25% in a year, Barron's says »

Flex (FLEX) is using…

FLEX

Flex

$16.74

-0.07 (-0.42%)

AAPL

Apple

$150.27

-0.07 (-0.05%)

LNVGY

Lenovo

$12.63

0.18 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

LUK

Leucadia

$26.45

0.03 (0.11%)

07:46
07/22/17
07/22
07:46
07/22/17
07:46
Periodicals
Leucadia shareholders to 'finally' see reward, Barron's says »

Five years after Leucadia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$46.59

0.08 (0.17%)

07:39
07/22/17
07/22
07:39
07/22/17
07:39
Periodicals
Morgan Stanley CEO would not kill off Dodd-Frank, Barron's reports »

Morgan Stanley CEO James…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$46.59

0.08 (0.17%)

, JPM

JPMorgan

$90.89

-0.31 (-0.34%)

07:34
07/22/17
07/22
07:34
07/22/17
07:34
Periodicals
Big bank profits could be lifted 30% by deregulation, Barron's says »

While a major overhaul is…

MS

Morgan Stanley

$46.59

0.08 (0.17%)

JPM

JPMorgan

$90.89

-0.31 (-0.34%)

GS

Goldman Sachs

$220.18

-2.12 (-0.95%)

C

Citi

$66.00

-0.36 (-0.54%)

STT

State Street

$90.99

0.12 (0.13%)

BK

BNY Mellon

$53.36

-0.55 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 12

    Oct

  • 17

    Oct

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

BCC

Boise Cascade

$29.35

0.4 (1.38%)

, CAT

Caterpillar

$106.59

-0.73 (-0.68%)

07:19
07/22/17
07/22
07:19
07/22/17
07:19
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

BCC

Boise Cascade

$29.35

0.4 (1.38%)

CAT

Caterpillar

$106.59

-0.73 (-0.68%)

CPB

Campbell Soup

$52.00

0.08 (0.15%)

LVB

Steinway Musical

GLW

Corning

$31.85

0.14 (0.44%)

MRK

Merck

$62.63

-0.31 (-0.49%)

PFE

Pfizer

$33.48

-0.06 (-0.18%)

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

AET

Aetna

$156.31

0.58 (0.37%)

ANTM

Anthem

$190.65

-0.04 (-0.02%)

CNC

Centene

$84.73

-0.67 (-0.78%)

CI

Cigna

$174.23

-0.26 (-0.15%)

HNT

Health Net

HUM

Humana

$235.92

0.09 (0.04%)

MOH

Molina Healthcare

$71.15

-0.9 (-1.25%)

UNH

UnitedHealth

$191.78

0.28 (0.15%)

WCG

WellCare

$183.87

0.1 (0.05%)

X

U.S. Steel

$23.68

-0.47 (-1.95%)

STLD

Steel Dynamics

$37.51

-0.18 (-0.48%)

NUE

Nucor

$60.23

0.31 (0.52%)

CYH

Community Health

$9.27

0.01 (0.11%)

HCA

HCA Holdings

$85.73

-0.03 (-0.03%)

LPNT

LifePoint

$65.35

-0.15 (-0.23%)

THC

Tenet

$20.65

-0.02 (-0.10%)

UHS

Universal Health

$124.42

-0.58 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 28

    Jul

  • 30

    Jul

  • 01

    Aug

  • 01

    Aug

  • 02

    Aug

  • 02

    Aug

  • 02

    Aug

  • 02

    Aug

  • 03

    Aug

  • 03

    Aug

  • 04

    Aug

  • 04

    Aug

  • 08

    Aug

  • 14

    Aug

  • 23

    Aug

  • 27

    Aug

  • 22

    Sep

  • 26

    Sep

  • 27

    Sep

MET

MetLife

$54.65

0.07 (0.13%)

18:20
07/21/17
07/21
18:20
07/21/17
18:20
Periodicals
U.S. regulators to go over MetLife suit at July 28 meeting, Reuters says »

Leaders at the U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 14

    Aug

  • 15

    Aug

OTEX

OpenText

$33.06

-0.02 (-0.06%)

, COVS

Covisint

18:11
07/21/17
07/21
18:11
07/21/17
18:11
Hot Stocks
OpenText says Covisint proposal shows 'compelling' overall value »

OpenText (OTEX) announced…

OTEX

OpenText

$33.06

-0.02 (-0.06%)

COVS

Covisint

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

TOSBF

Toshiba, also use TOSYY

$2.47

0.1002 (4.23%)

, TOSYY

Toshiba, also use TOSBF

$14.90

0.8 (5.67%)

17:39
07/21/17
07/21
17:39
07/21/17
17:39
Periodicals
Toshiba sees bringing in about $360 in profit from Landis+Gyr IPO, Nikkei says »

Toshiba sees reaping…

TOSBF

Toshiba, also use TOSYY

$2.47

0.1002 (4.23%)

TOSYY

Toshiba, also use TOSBF

$14.90

0.8 (5.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MON

Monsanto

$117.38

0.37 (0.32%)

17:38
07/21/17
07/21
17:38
07/21/17
17:38
Periodicals
Breaking Periodicals news story on Monsanto »

Monsanto says some…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSFG

First Savings Financial Group

$53.02

0.095 (0.18%)

17:34
07/21/17
07/21
17:34
07/21/17
17:34
Hot Stocks
First Savings Financial Group , First National Bank of Odon to merge »

First Savings Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAUH

National American University

$2.36

-0.0236 (-0.99%)

17:26
07/21/17
07/21
17:26
07/21/17
17:26
Hot Stocks
National American University to acquire H-PU, terms not disclosed »

National American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

QEP

QEP Resources

$9.22

-0.27 (-2.85%)

17:25
07/21/17
07/21
17:25
07/21/17
17:25
Hot Stocks
QEP Resources names Mary Shafer-Malicki to board of directors »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

CLSN

Celsion

$1.85

-0.07 (-3.65%)

17:18
07/21/17
07/21
17:18
07/21/17
17:18
Syndicate
Celsion files to sell 4.87M shares of common stock for holders »

Issuable upon exercise of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REED

Reed's

16:54
07/21/17
07/21
16:54
07/21/17
16:54
Hot Stocks
Breaking Hot Stocks news story on Reed's »

Raptor/Harbor Reeds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.